Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
-$313K 1091
2024
Q4
Hold
0
1091
2024
Q3
Hold
0
985
2024
Q2
Hold
0
902
2024
Q1
Hold
0
802
2023
Q4
Hold
0
622
2023
Q3
Hold
0
596
2023
Q2
Hold
0
639
2023
Q1
Hold
0
563
2022
Q4
Hold
0
415
2022
Q3
Hold
0
414
2022
Q2
Sell
-1,400
Closed -$343K 409
2022
Q1
$339K Buy
+1,400
New +$322K 0.01% 429

Other funds holding AMGN

Savant Capital's AMGN Position: Q2 2026 in Review

Savant Capital increased its Amgen (AMGN) stake by 58% in Q2 2026, buying an estimated $5.06M and bringing the position to 40,234 shares worth $15M. The position accounts for 0.04% of the portfolio, ranked #229.

Savant Capital first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Savant Capital held 40,234 shares of Amgen worth $15M as of Q2 2026.
  • Savant Capital bought 14,768 Amgen shares in Q2 2026, an estimated $5.06M.
  • Amgen made up 0.04% of Savant Capital's portfolio in Q2 2026, its #229 holding.
  • Savant Capital first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.